These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11351645)

  • 1. [Hypo- and hyperalphalipoproteinemia and genetic abnormalties in reverse cholesterol transport system].
    Matsuyama A; Yamashita S
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():539-44. PubMed ID: 11351645
    [No Abstract]   [Full Text] [Related]  

  • 2. Impairment of a protective system against atherosclerosis--genetic disorders in HDL metabolism.
    Matsuzawa Y; Sakai N; Yamashita S
    Jpn Circ J; 1991 Oct; 55(10):1010-5. PubMed ID: 1744976
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholesteryl ester transfer protein gene mutations in Brazilian hyperalphalipoproteinemia.
    Kaplan DB; Schreiber R; Oliveira HC; Harada LM; Nakamura RT; Pinheiro HP; Tentor J; Cruz ML; de Faria EC
    Clin Genet; 2006 May; 69(5):455-7. PubMed ID: 16650090
    [No Abstract]   [Full Text] [Related]  

  • 4. [Apolipoproteinopathies].
    Assmann G
    Klin Wochenschr; 1983 Feb; 61(4):169-82. PubMed ID: 6405080
    [No Abstract]   [Full Text] [Related]  

  • 5. [New approach to pathogenesis of genetic hyperlipoproteinemias].
    Koizumi J; Inazu A; Mabuchi H
    Rinsho Byori; 1993 May; 41(5):519-26. PubMed ID: 8350515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compound heterozygote of cholesteryl-ester transfer protein deficiency in a patient with hyperalphalipoproteinemia.
    Takegoshi T; Haba T; Kitoh C; Inazu A; Koizumi J; Mabuchi H; Takeda R
    Atherosclerosis; 1992 Sep; 96(1):83-5. PubMed ID: 1418105
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypo- and hyper alphalipoproteinemia and genetic abnormalities in reverse cholesterol transport system].
    Matsuyama A; Yamashita S
    Nihon Rinsho; 1999 Dec; 57(12):2729-34. PubMed ID: 10638204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesteryl ester transfer protein deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA.
    Gotoda T; Kinoshita M; Shimano H; Harada K; Shimada M; Ohsuga J; Teramoto T; Yazaki Y; Yamada N
    Biochem Biophys Res Commun; 1993 Jul; 194(1):519-24. PubMed ID: 8333866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of lipoprotein disorders.
    Breslow JL
    Circulation; 1993 Apr; 87(4 Suppl):III16-21. PubMed ID: 8462176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of familial hyper- and hypolipoproteinemias: the Princeton School District Family Study.
    Laskarzewski PM; Khoury P; Morrison JA; Kelly K; Mellies MJ; Glueck CJ
    Metabolism; 1982 Jun; 31(6):558-77. PubMed ID: 7078433
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of Tangier disease].
    Kosaka A; Hayashi H
    Rinsho Byori; 1988 Aug; 36(8):988-91. PubMed ID: 3149352
    [No Abstract]   [Full Text] [Related]  

  • 12. [CETP inhibitor].
    Inazu A; Mabuchi H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():671-4. PubMed ID: 11347151
    [No Abstract]   [Full Text] [Related]  

  • 13. [Classification of dyslipoproteinemias of genetic origin].
    Brousseau T; Fruchart JC
    Ann Med Interne (Paris); 1993; 144(4):275-81. PubMed ID: 8368721
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cholesteryl ester transfer protein (CETP) deficiency and increased HDL cholesterol levels (hyperalphalipoproteinemia)].
    Inazu A; Koizumi J; Mabuchi H
    Rinsho Byori; 1996 Apr; 44(4):322-6. PubMed ID: 8847813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High density lipoproteins with poor reactivity to cholesteryl ester transfer reaction observed in a homozygote of familial hyperalphalipoproteinemia.
    Yokoyama S; Kurasawa T; Nishikawa O; Yamamoto A
    Artery; 1986; 14(1):43-51. PubMed ID: 3789924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.
    Inazu A; Brown ML; Hesler CB; Agellon LB; Koizumi J; Takata K; Maruhama Y; Mabuchi H; Tall AR
    N Engl J Med; 1990 Nov; 323(18):1234-8. PubMed ID: 2215607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary hyperalphalipoproteinemia].
    Inazu A; Koizumi J
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():90-3. PubMed ID: 11347189
    [No Abstract]   [Full Text] [Related]  

  • 18. [Genetic hypolipoproteinemias].
    Bakir R; Chanu B; Rouffy J
    Sem Hop; 1983 Dec; 59(49):3456-60. PubMed ID: 6320428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholesterol ester transfer protein. A major player in cholesterol metabolism].
    Hansen PR
    Ugeskr Laeger; 1999 Sep; 161(38):5295-8. PubMed ID: 10536513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic hypolipoproteinemia].
    Bakir R; Chanu B; Rouffy J
    Pathol Biol (Paris); 1983 Sep; 31(7):601-5. PubMed ID: 6355992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.